Effects of Omega 3 in Hemodialysis Patients | NCT00431899

Studies
Effects of Omega 3 in Hemodialysis Patients

NCT00431899

Sponsor

Laboratoire Régional de Nutrition Humaine

Status

Completed

Last Update Posted

Mar 3, 2016Estimated

Enrollment

Phase

Not Applicable

Conditions

Hemodialysis
End Stage Renal Disease

Interventions

fish oil supplementation

Countries

France

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

Status Module

Record Verification Date

Feb 2007

Overall Recruitment Status or Expanded Access Status

Completed

Last Known Status

Not provided

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

Start Date

May 2003

Primary Completion Date

Not provided

Completion Date

Nov 2003

First Submitted Date

Feb 3, 2007

First Submission Date that Met QC Criteria

Feb 3, 2007

First Posted Date

Feb 6, 2007Estimated

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

Mar 2, 2016

Last Update Posted Date

Mar 3, 2016Estimated

Description Module

Brief Summary

The aim of the study was to determine the effects of a 3-week fish oil oral supplementation on the metabolic fate and thermogenic effect of an oral glucose load in hemodialysis patients.

Detailed Description

Not provided

Design Module

Study Type

Interventional

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Not provided

Target Follow-Up Duration

Not provided

Phases

Not Applicable

Interventional Study Design

Allocation

Biospecimen

No data available

No data is available for this block.

Enrollment

Name	Type	Description	Arm Group Labels	Other Names
fish oil supplementation	Behavioral

Eligibility Module

Eligibility Criteria

Inclusion Criteria:

hemodialysis at least 6 months duration end stage renal disease

Exclusion Criteria:

- Age < 18 y ou > 75 y
Hemodialysis < 6 months
Diabetes, obesity
allergy to fish
Asthma
glucocorticoïds, propranolol,, Immunosuppressive drugs, Insulin, Somatostatin
erythropoïetin < 3 months
Cancer
Hemoglobin < 11 g/l
disease < 1 month
pregnancy
respiratory insufficiency
intensive sport practice
refusal

Accepts Healthy Volunteers

Sex

All

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

18 Years

Maximum Age

75 Years

Standard Ages

AdultOlder Adult

Study Population

Not provided

Sampling Method

Not provided

Contacts/Locations Module

Central Contacts

Not provided

Overall Officials

Name	Affiliation	Role
Jacques Delarue, MD,PhD	CHU Cavale Blanche F-29200 Brest	Principal Investigator

Locations

Facility	Status	City	State	ZIP	Country	Contacts
Laboratoire Régional de Nutrition Humaine		Brest		F-29200	France

Condition Browse Module

MeSH Terms

ID	Term
D007676	Kidney Failure, Chronic
D007333	Insulin Resistance

Ancestor Terms

ID	Term
D051436	Renal Insufficiency, Chronic
D051437	Renal Insufficiency
D007674	Kidney Diseases
D014570	Urologic Diseases

Browse Leaves

Not provided

Browse Branches

Not provided

Measure	Description	Time Frame
plasma glucose utilization
glucose-induced thermogenesis